Safety Analysis of Apatinib Combined with Chemotherapy in the Treatment of Advanced Gastric Carcinoma: A Randomised Controlled Trial

Table 2

Comparison of short-term efficacy (n (%)).

Group	n	CR	PR	SD	PD	DCR (%)
SG	37	5 (13.51%)	16 (43.24%)	5 (13.51%)	11 (29.73%)	70.27% (26/37)
RG	37	2 (5.41%)	7 (18.92%)	8 (21.62%)	20 (54.05%)	45.95% (17/37)
X^2						4.497
						0.034